Nova Oculus Partners have developed and plan to manufacture a medical device to treat age-related macular degeneration (AMD). Optometrists and other medical professionals will be able to lease the device so they can treat their patients who suffer from AMD.

Over 10 million people in the United States have a form of age-related macular degeneration, according to the National Eye Institute. The Institute also indicated that more than 1 in 10 people over 70 yrs. old has some vision loss due to AMD. Nova Oculus Partners realized how many people were affected by this disease and decided to create a new technology to help them regain their lost vision. This unique technology is at the forefront of ophthalmologic science.

Age-related macular degeneration is the number one cause of legal blindness in adults over the age of 50 years. The “baby boomers” are all over this age range. As this generation ages, there will be an increased number of people in the United States with AMD. Nova Oculus Partners will be able to meet a growing population of people with macular degeneration.

The team at Nova Oculus Partners brings a variety of disciplines to the company. Michael Samuel M.D., our Medical Advisor, whom is nationally known for research, clinical work, and surgery. He was a part of a team that performed the first surgical implant of stem cells for dry macular degeneration. We are very fortunate to have him as our medical advisor. Dr. George O’Clock, Ph.D. is our Chief Science Advisor. The extensive experience that he has in technologies that successfully treats eye disease makes him the ideal advisor for this mission.

While the technology still needs to complete a regulatory approval process with the FDA, it is expected to be the future of treating patients with AMD.

Read more about our exciting new technology on our website or contact us for more information. please call us at (760) 292-2812 or visit our website. They are located at 74-900 Highway 111, Suite 127, Indian Wells, California 92210.